Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2007, Vol.25 (31), p.5735-5744
Hauptverfasser: NELL, Patricia, KOHL, Katrin S, GRAHAM, Philip L, LARUSSA, Philip S, MARCY, S. Michael, FULGINITI, Vincent A, MARTIN, Bryan, MCMAHON, Ann, NORTON, Scott A, TROLIN, Ingrid
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5744
container_issue 31
container_start_page 5735
container_title Vaccine
container_volume 25
creator NELL, Patricia
KOHL, Katrin S
GRAHAM, Philip L
LARUSSA, Philip S
MARCY, S. Michael
FULGINITI, Vincent A
MARTIN, Bryan
MCMAHON, Ann
NORTON, Scott A
TROLIN, Ingrid
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_18941324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18941324</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_189413243</originalsourceid><addsrcrecordid>eNqNUc1uEzEQXlCRCIV3mAtSkRyxm6SQ9gZNERwqIcGBWzWxZ3eNvLblsbfdPncfgElTCdITJ8vj79fzvJo164_L-eK0WR9Vs3rxYTVfNfWvl9Ur5t91XZ8um7PZs_vvKXSJmO1IMKLW1lsEZEAPaEZKTEAj-QxtcC7cWN8B3cbAJRHk8Jcy2lQYzuEChWGolWG2QUS8ga5YQ856YggtGMwIWtRI7xBKIOgmtqwewFHSiB8-sAVuh6F4e7e_M7aUp73EOXxOtuuzjHdquA3pEZRFB5Oxd2RAH-bhp4HakA6L8j9ND7xPJGfsJ4e3u6jkNcUenajy-0-byytJzxSz1TCQF_LuQUEr3K6QgiJm0aF4GuBiDHlJhbmHk823zY93ChJyryD3KQzboKccosigAk3OFbdXwy1r2ZUC603Zt1XAN4IQQ_V0GYe1FPRTDPJbVr-uXrTomN48nsfV2y-XPy--ziOyRtcm9NrydUx2wDRdN-uzVbNcrJb_i_sDRfHfig</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</title><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>NELL, Patricia ; KOHL, Katrin S ; GRAHAM, Philip L ; LARUSSA, Philip S ; MARCY, S. Michael ; FULGINITI, Vincent A ; MARTIN, Bryan ; MCMAHON, Ann ; NORTON, Scott A ; TROLIN, Ingrid</creator><creatorcontrib>NELL, Patricia ; KOHL, Katrin S ; GRAHAM, Philip L ; LARUSSA, Philip S ; MARCY, S. Michael ; FULGINITI, Vincent A ; MARTIN, Bryan ; MCMAHON, Ann ; NORTON, Scott A ; TROLIN, Ingrid</creatorcontrib><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Applied microbiology ; Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; Microbiology ; Miscellaneous ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Virology</subject><ispartof>Vaccine, 2007, Vol.25 (31), p.5735-5744</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18941324$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>NELL, Patricia</creatorcontrib><creatorcontrib>KOHL, Katrin S</creatorcontrib><creatorcontrib>GRAHAM, Philip L</creatorcontrib><creatorcontrib>LARUSSA, Philip S</creatorcontrib><creatorcontrib>MARCY, S. Michael</creatorcontrib><creatorcontrib>FULGINITI, Vincent A</creatorcontrib><creatorcontrib>MARTIN, Bryan</creatorcontrib><creatorcontrib>MCMAHON, Ann</creatorcontrib><creatorcontrib>NORTON, Scott A</creatorcontrib><creatorcontrib>TROLIN, Ingrid</creatorcontrib><title>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</title><title>Vaccine</title><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Virology</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNUc1uEzEQXlCRCIV3mAtSkRyxm6SQ9gZNERwqIcGBWzWxZ3eNvLblsbfdPncfgElTCdITJ8vj79fzvJo164_L-eK0WR9Vs3rxYTVfNfWvl9Ur5t91XZ8um7PZs_vvKXSJmO1IMKLW1lsEZEAPaEZKTEAj-QxtcC7cWN8B3cbAJRHk8Jcy2lQYzuEChWGolWG2QUS8ga5YQ856YggtGMwIWtRI7xBKIOgmtqwewFHSiB8-sAVuh6F4e7e_M7aUp73EOXxOtuuzjHdquA3pEZRFB5Oxd2RAH-bhp4HakA6L8j9ND7xPJGfsJ4e3u6jkNcUenajy-0-byytJzxSz1TCQF_LuQUEr3K6QgiJm0aF4GuBiDHlJhbmHk823zY93ChJyryD3KQzboKccosigAk3OFbdXwy1r2ZUC603Zt1XAN4IQQ_V0GYe1FPRTDPJbVr-uXrTomN48nsfV2y-XPy--ziOyRtcm9NrydUx2wDRdN-uzVbNcrJb_i_sDRfHfig</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>NELL, Patricia</creator><creator>KOHL, Katrin S</creator><creator>GRAHAM, Philip L</creator><creator>LARUSSA, Philip S</creator><creator>MARCY, S. Michael</creator><creator>FULGINITI, Vincent A</creator><creator>MARTIN, Bryan</creator><creator>MCMAHON, Ann</creator><creator>NORTON, Scott A</creator><creator>TROLIN, Ingrid</creator><general>Elsevier</general><scope>IQODW</scope></search><sort><creationdate>2007</creationdate><title>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</title><author>NELL, Patricia ; KOHL, Katrin S ; GRAHAM, Philip L ; LARUSSA, Philip S ; MARCY, S. Michael ; FULGINITI, Vincent A ; MARTIN, Bryan ; MCMAHON, Ann ; NORTON, Scott A ; TROLIN, Ingrid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_189413243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NELL, Patricia</creatorcontrib><creatorcontrib>KOHL, Katrin S</creatorcontrib><creatorcontrib>GRAHAM, Philip L</creatorcontrib><creatorcontrib>LARUSSA, Philip S</creatorcontrib><creatorcontrib>MARCY, S. Michael</creatorcontrib><creatorcontrib>FULGINITI, Vincent A</creatorcontrib><creatorcontrib>MARTIN, Bryan</creatorcontrib><creatorcontrib>MCMAHON, Ann</creatorcontrib><creatorcontrib>NORTON, Scott A</creatorcontrib><creatorcontrib>TROLIN, Ingrid</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NELL, Patricia</au><au>KOHL, Katrin S</au><au>GRAHAM, Philip L</au><au>LARUSSA, Philip S</au><au>MARCY, S. Michael</au><au>FULGINITI, Vincent A</au><au>MARTIN, Bryan</au><au>MCMAHON, Ann</au><au>NORTON, Scott A</au><au>TROLIN, Ingrid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</atitle><jtitle>Vaccine</jtitle><date>2007</date><risdate>2007</risdate><volume>25</volume><issue>31</issue><spage>5735</spage><epage>5744</epage><pages>5735-5744</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><cop>Oxford</cop><pub>Elsevier</pub></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2007, Vol.25 (31), p.5735-5744
issn 0264-410X
1873-2518
language eng
recordid cdi_pascalfrancis_primary_18941324
source Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Applied microbiology
Biological and medical sciences
Fundamental and applied biological sciences. Psychology
Microbiology
Miscellaneous
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Virology
title Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T22%3A04%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progressive%20vaccinia%20as%20an%20adverse%20event%20following%20exposure%20to%20vaccinia%20virus%20:%20Case%20definition%20and%20guidelines%20of%20data%20collection,%20analysis,%20and%20presentation%20of%20immunization%20safety%20data%20:%20Brighton%20collaboration%20standardized%20case%20definitions%20and%20guidelines%20for%20adverse%20events%20following%20immunization%20(anaphylaxis,%20encephalitis/ADEM,%20aseptic%20meningitis,%20fatigue,%20unesplained%20sudden%20death%20(DIDS),%20rash,%20thrombocytopenia,%20cellulitis,%20abscess,%20induration,%20swelling,%20vaccinia%20virus%20adverse%20events,%20hypotonic&rft.jtitle=Vaccine&rft.au=NELL,%20Patricia&rft.date=2007&rft.volume=25&rft.issue=31&rft.spage=5735&rft.epage=5744&rft.pages=5735-5744&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E18941324%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true